Sarepta's EMBARK study confirms Elevidys offers sustained Duchenne treatment benefits, including motor function improvement ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received ... Poseida - equivalent to 66% of the California company's stock - which had been tendered by shareholders at a price ...

SNY, ABBV, RHHBY and NVS will announce Q4 results and regular pipeline and regulatory updates next week.

I hope to see you there. Analyst’s Disclosure: I/we have a beneficial long position in the shares of RHHBY either through stock ownership, options, or other derivatives. I wrote this article ...

Poseida Therapeutics (PSTX) will cease trading on Nasdaq after the merger and will become a wholly owned subsidiary of Roche (OTCQX:RHHBY). PSTX stock price traded marginally higher, up 0.42% to $ ...

RHHBY – Free Report) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,453 shares of the company’s stock after ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CVS Health (NYSE:CVS) has submitted a letter to HHS Secretary Alex Azar emphasizing its support for the Administration's goal of lowering drug prices. It says its PBM ...

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year ...

Get daily trade setups, exclusive stock picks, and real-time alerts today. Swiss pharmaceutical giant Roche Holding AG RHHBY reportedly has no plans for job cuts despite facing recent challenges ...